CN103173412B - 小鼠抗人cd20单克隆抗体及分泌该单克隆抗体的杂交瘤细胞株 - Google Patents
小鼠抗人cd20单克隆抗体及分泌该单克隆抗体的杂交瘤细胞株 Download PDFInfo
- Publication number
- CN103173412B CN103173412B CN201210528184.XA CN201210528184A CN103173412B CN 103173412 B CN103173412 B CN 103173412B CN 201210528184 A CN201210528184 A CN 201210528184A CN 103173412 B CN103173412 B CN 103173412B
- Authority
- CN
- China
- Prior art keywords
- monoclonal antibody
- variable region
- seq
- hybridoma cell
- cell strain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 210000004408 hybridoma Anatomy 0.000 title claims abstract description 25
- 229940124292 CD20 monoclonal antibody Drugs 0.000 title claims abstract description 16
- 230000003248 secreting effect Effects 0.000 title abstract description 4
- 101000897405 Homo sapiens B-lymphocyte antigen CD20 Proteins 0.000 claims abstract description 48
- 102100022005 B-lymphocyte antigen CD20 Human genes 0.000 claims abstract description 46
- 125000003275 alpha amino acid group Chemical group 0.000 claims abstract 6
- 238000002649 immunization Methods 0.000 claims description 9
- 230000003053 immunization Effects 0.000 claims description 8
- 230000009465 prokaryotic expression Effects 0.000 claims description 3
- 230000028327 secretion Effects 0.000 claims description 3
- 108060003951 Immunoglobulin Proteins 0.000 claims description 2
- 102000018358 immunoglobulin Human genes 0.000 claims description 2
- 108020004414 DNA Proteins 0.000 abstract description 8
- 230000014509 gene expression Effects 0.000 abstract description 5
- 238000011160 research Methods 0.000 abstract description 4
- 238000013115 immunohistochemical detection Methods 0.000 abstract description 2
- 102000053602 DNA Human genes 0.000 abstract 3
- 101000599862 Homo sapiens Intercellular adhesion molecule 3 Proteins 0.000 abstract 1
- 102100037871 Intercellular adhesion molecule 3 Human genes 0.000 abstract 1
- 210000003719 b-lymphocyte Anatomy 0.000 description 13
- 238000000034 method Methods 0.000 description 13
- 210000004027 cell Anatomy 0.000 description 12
- 108090000623 proteins and genes Proteins 0.000 description 12
- 150000001413 amino acids Chemical class 0.000 description 10
- 210000001519 tissue Anatomy 0.000 description 10
- 210000004698 lymphocyte Anatomy 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 239000000427 antigen Substances 0.000 description 8
- 102000036639 antigens Human genes 0.000 description 8
- 108091007433 antigens Proteins 0.000 description 8
- 210000001185 bone marrow Anatomy 0.000 description 8
- 210000002966 serum Anatomy 0.000 description 7
- 238000002965 ELISA Methods 0.000 description 6
- 238000010790 dilution Methods 0.000 description 6
- 239000012895 dilution Substances 0.000 description 6
- 239000013612 plasmid Substances 0.000 description 6
- 206010009152 Chronic tonsillitis Diseases 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 238000012408 PCR amplification Methods 0.000 description 5
- 239000000872 buffer Substances 0.000 description 5
- 239000003153 chemical reaction reagent Substances 0.000 description 5
- 239000002299 complementary DNA Substances 0.000 description 5
- 230000036039 immunity Effects 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 239000002609 medium Substances 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 235000018102 proteins Nutrition 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 206010044008 tonsillitis Diseases 0.000 description 5
- 208000003950 B-cell lymphoma Diseases 0.000 description 4
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 4
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 4
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 238000002347 injection Methods 0.000 description 4
- 239000007924 injection Substances 0.000 description 4
- 239000012188 paraffin wax Substances 0.000 description 4
- 238000012216 screening Methods 0.000 description 4
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 4
- 230000009466 transformation Effects 0.000 description 4
- 206010003445 Ascites Diseases 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 3
- 108091028043 Nucleic acid sequence Proteins 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 3
- 239000002671 adjuvant Substances 0.000 description 3
- 238000001042 affinity chromatography Methods 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 229940088598 enzyme Drugs 0.000 description 3
- 239000013604 expression vector Substances 0.000 description 3
- 238000011532 immunohistochemical staining Methods 0.000 description 3
- 229930027917 kanamycin Natural products 0.000 description 3
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 3
- 229960000318 kanamycin Drugs 0.000 description 3
- 229930182823 kanamycin A Natural products 0.000 description 3
- 238000002372 labelling Methods 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 239000013642 negative control Substances 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 210000004180 plasmocyte Anatomy 0.000 description 3
- 229960000856 protein c Drugs 0.000 description 3
- 238000003259 recombinant expression Methods 0.000 description 3
- 238000010839 reverse transcription Methods 0.000 description 3
- 235000011149 sulphuric acid Nutrition 0.000 description 3
- 239000001117 sulphuric acid Substances 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 101100495232 Homo sapiens MS4A1 gene Proteins 0.000 description 2
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 2
- 241001494479 Pecora Species 0.000 description 2
- 206010035226 Plasma cell myeloma Diseases 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- 241000607142 Salmonella Species 0.000 description 2
- 238000011091 antibody purification Methods 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 230000007910 cell fusion Effects 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 230000024835 cytogamy Effects 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 238000004043 dyeing Methods 0.000 description 2
- 239000010419 fine particle Substances 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 2
- 238000007654 immersion Methods 0.000 description 2
- 201000000050 myeloid neoplasm Diseases 0.000 description 2
- -1 polyoxyethylene Polymers 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 235000020183 skimmed milk Nutrition 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- IVLXQGJVBGMLRR-UHFFFAOYSA-N 2-aminoacetic acid;hydron;chloride Chemical compound Cl.NCC(O)=O IVLXQGJVBGMLRR-UHFFFAOYSA-N 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 102000012410 DNA Ligases Human genes 0.000 description 1
- 108010061982 DNA Ligases Proteins 0.000 description 1
- 241000672609 Escherichia coli BL21 Species 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 208000028018 Lymphocytic leukaemia Diseases 0.000 description 1
- 206010025323 Lymphomas Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 description 1
- 208000015914 Non-Hodgkin lymphomas Diseases 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 208000006664 Precursor Cell Lymphoblastic Leukemia-Lymphoma Diseases 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 238000001261 affinity purification Methods 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000003995 blood forming stem cell Anatomy 0.000 description 1
- 238000010241 blood sampling Methods 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 230000011712 cell development Effects 0.000 description 1
- 230000006727 cell loss Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- 239000004020 conductor Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 239000012228 culture supernatant Substances 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 229960000935 dehydrated alcohol Drugs 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000013613 expression plasmid Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000012447 hatching Effects 0.000 description 1
- 238000002991 immunohistochemical analysis Methods 0.000 description 1
- 230000002055 immunohistochemical effect Effects 0.000 description 1
- 238000012151 immunohistochemical method Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 201000011649 lymphoblastic lymphoma Diseases 0.000 description 1
- 208000003747 lymphoid leukemia Diseases 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 229940126619 mouse monoclonal antibody Drugs 0.000 description 1
- 229940005654 nitrite ion Drugs 0.000 description 1
- 210000002741 palatine tonsil Anatomy 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 210000003720 plasmablast Anatomy 0.000 description 1
- 210000002706 plastid Anatomy 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000001742 protein purification Methods 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 239000006152 selective media Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 210000004988 splenocyte Anatomy 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 238000002626 targeted therapy Methods 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 239000011534 wash buffer Substances 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Landscapes
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210528184.XA CN103173412B (zh) | 2012-12-07 | 2012-12-07 | 小鼠抗人cd20单克隆抗体及分泌该单克隆抗体的杂交瘤细胞株 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210528184.XA CN103173412B (zh) | 2012-12-07 | 2012-12-07 | 小鼠抗人cd20单克隆抗体及分泌该单克隆抗体的杂交瘤细胞株 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103173412A CN103173412A (zh) | 2013-06-26 |
CN103173412B true CN103173412B (zh) | 2015-04-22 |
Family
ID=48633604
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210528184.XA Expired - Fee Related CN103173412B (zh) | 2012-12-07 | 2012-12-07 | 小鼠抗人cd20单克隆抗体及分泌该单克隆抗体的杂交瘤细胞株 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103173412B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107446046A (zh) * | 2017-07-05 | 2017-12-08 | 无锡傲锐东源生物科技有限公司 | 抗cd20蛋白单克隆抗体及其用途 |
WO2019023410A1 (en) * | 2017-07-28 | 2019-01-31 | Phanes Therapeutics, Inc. | ANTI-TIM-1 ANTIBODIES AND USES THEREOF |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1420129A (zh) * | 2001-11-16 | 2003-05-28 | 上海中信国健药业有限公司 | 抗cd20人源化单克隆抗体 |
CN1729203A (zh) * | 2002-10-17 | 2006-02-01 | 根马布股份公司 | 抗cd20的人单克隆抗体 |
CN1931877A (zh) * | 2005-09-13 | 2007-03-21 | 北京天广实生物技术有限公司 | 一种抗cd20嵌合抗体的制备及其用途 |
CN101203607A (zh) * | 2005-03-31 | 2008-06-18 | 生物医药股份有限公司 | 抗cd20单克隆抗体 |
-
2012
- 2012-12-07 CN CN201210528184.XA patent/CN103173412B/zh not_active Expired - Fee Related
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1420129A (zh) * | 2001-11-16 | 2003-05-28 | 上海中信国健药业有限公司 | 抗cd20人源化单克隆抗体 |
CN1729203A (zh) * | 2002-10-17 | 2006-02-01 | 根马布股份公司 | 抗cd20的人单克隆抗体 |
CN101203607A (zh) * | 2005-03-31 | 2008-06-18 | 生物医药股份有限公司 | 抗cd20单克隆抗体 |
CN1931877A (zh) * | 2005-09-13 | 2007-03-21 | 北京天广实生物技术有限公司 | 一种抗cd20嵌合抗体的制备及其用途 |
Non-Patent Citations (2)
Title |
---|
利用基因重组抗原研制人CD20单克隆抗体及其功能的研究;李爱玲 等;《中华微生物学和免疫学杂志》;20020731;第22卷(第4期);385-388 * |
鼠抗人CD20单克隆抗体的制备与鉴定;包红霞 等;《细胞与分子免疫学杂志》;20091231;第25卷(第5期);454-456 * |
Also Published As
Publication number | Publication date |
---|---|
CN103173412A (zh) | 2013-06-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103923214B (zh) | 抗肝癌干细胞单克隆抗体及其应用 | |
CN103173413A (zh) | 小鼠抗人β-Catenin单克隆抗体及分泌该单克隆抗体的杂交瘤细胞株 | |
CN108467432A (zh) | 抗E-cadherin蛋白的单克隆抗体及其细胞株、制备方法和应用 | |
CN113234161A (zh) | 抗cd3蛋白单克隆抗体及其细胞株、制备方法和应用 | |
CN113072642B (zh) | 抗oct3/4蛋白单克隆抗体及其细胞株、制备方法和应用 | |
CN104894074B (zh) | 分泌s100a9单克隆抗体的杂交瘤细胞株、单克隆抗体及其应用 | |
CN101463344B (zh) | 抗人Her2单克隆抗体杂交瘤细胞系、单克隆抗体、试剂盒及其用途 | |
CN110903389A (zh) | 抗gfap蛋白单克隆抗体、细胞系及其制备方法和应用 | |
CN115724958A (zh) | 抗诺如病毒gⅱ基因组衣壳蛋白vp1的单克隆抗体及其应用 | |
CN109369803A (zh) | 一种抗狂犬病毒g蛋白的纳米抗体及其应用 | |
CN105198987A (zh) | 一种抗化脓隐秘杆菌plo蛋白单克隆抗体及其识别的抗原表位和应用 | |
CN103880956B (zh) | 抗muc1单克隆抗体及其轻链和重链可变区 | |
CN103173412B (zh) | 小鼠抗人cd20单克隆抗体及分泌该单克隆抗体的杂交瘤细胞株 | |
CN105646705A (zh) | 小鼠抗人gfap单克隆抗体及分泌该单克隆抗体的杂交瘤细胞株 | |
CN103224561A (zh) | 葡萄球菌肠毒素小分子抗体及制备方法及用途 | |
CN103289962B (zh) | 小鼠抗人cd23单克隆抗体及分泌该单克隆抗体的杂交瘤细胞株 | |
CN105646711A (zh) | 小鼠抗人ck8单克隆抗体及分泌该单克隆抗体的杂交瘤细胞株 | |
CN103173416A (zh) | 小鼠抗人ck19单克隆抗体及分泌该单克隆抗体的杂交瘤细胞株 | |
CN103173417B (zh) | 小鼠抗人cea单克隆抗体及分泌该单克隆抗体的杂交瘤细胞株 | |
CN106754740A (zh) | 小鼠抗人mdr‑1单克隆抗体及分泌该单克隆抗体的杂交瘤细胞株 | |
CN102776154A (zh) | 小鼠抗人β-Tubulin单克隆抗体及分泌该单克隆抗体的杂交瘤细胞株 | |
CN108034638A (zh) | 小鼠抗人Desmin单克隆抗体及分泌该单克隆抗体的杂交瘤细胞株 | |
CN101759781B (zh) | 一种细菌表层黏附蛋白及其用途 | |
CN103173414B (zh) | 小鼠抗人p504s单克隆抗体及分泌该单克隆抗体的杂交瘤细胞株 | |
CN113845592B (zh) | 抗ck5/6蛋白单克隆抗体及其细胞株、制备方法和应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee |
Owner name: TIANJIN SUNGENE BIOTECH CO., LTD. Free format text: FORMER NAME: TIANJIN SUNGENE BIOTECHNOLOGY CO., LTD. |
|
CP01 | Change in the name or title of a patent holder |
Address after: 300457, Tianjin Binhai New Area Tanggu economic and Technological Development Zone Fourth Avenue 80 days big science and Technology Park C5-106/311 Patentee after: TIANJIN SUNGENE BIOTECH Co.,Ltd. Address before: 300457, Tianjin Binhai New Area Tanggu economic and Technological Development Zone Fourth Avenue 80 days big science and Technology Park C5-106/311 Patentee before: TIANJIN SUNGENE BIOTECH Co.,Ltd. |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Mouse anti-human CD20 monoclonal antibody and hybridoma cell strain for secreting monoclonal antibody Effective date of registration: 20170508 Granted publication date: 20150422 Pledgee: Zheshang Bank, Limited by Share Ltd, Tianjin branch Pledgor: TIANJIN SUNGENE BIOTECH CO.,LTD. Registration number: 2017120000022 |
|
DD01 | Delivery of document by public notice | ||
DD01 | Delivery of document by public notice |
Addressee: Liu Chen Document name: payment instructions |
|
DD01 | Delivery of document by public notice | ||
DD01 | Delivery of document by public notice |
Addressee: Liu Chen Document name: Patent termination notice |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150422 Termination date: 20211207 |